---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-022471"
form_type: "8-K"
ticker: "ELVN"
cik: "0001672619"
company_name: "Enliven Therapeutics, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:47:35.782116+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Imara Inc. reports annual meeting results; elects directors, ratifies EY as auditor

## Summary
- Stockholders elected Rahul D. Ballal and Barbara J. Dalton as Class II directors for three-year terms expiring 2025.
- Ballal received 11,789,401 votes for and 1,791,276 withheld; Dalton had 11,786,912 for and 1,793,765 withheld.
- Ratification of Ernst & Young as independent auditor for FY 2022 passed with 18,806,373 votes for, 60,227 against, 46,749 abstentions.
- Meeting held on June 2, 2022; broker non-votes on director elections totaled 5,332,673.

## SEC filing metadata
- accession: 0001564590-22-022471
- form_type: 8-K
- ticker: ELVN
- cik: 0001672619
- company_name: Enliven Therapeutics, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/0001564590-22-022471-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/imra-8k_20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-022471
- JSON: https://secwatch.observer/filing/0001564590-22-022471.json
- Plain text: https://secwatch.observer/filing/0001564590-22-022471.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.